The chemotherapy of protozoal infections: whither?
D000818:Animals; D000965:Antimony / Q000627:therapeutic use; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006017:Glycolipids / Q000627:therapeutic use; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy; D007898:Leishmaniasis, Visceral / Q000188:drug therapy; D008081:Liposomes / Q000008:administration & dosage*; D008247:Lysosomes / Q000378:metabolism; D008288:Malaria / Q000188:drug therapy; D008536:Meglumine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds; D011319:Primaquine / Q000627:therapeutic use; D011528:Protozoan Infections / Q000188:drug therapy*; D014352:Trypanosomiasis / Q000188:drug therapy
D000981:Antiprotozoal Agents; D006017:Glycolipids; D008081:Liposomes; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony; D011319:Primaquine; D000967:Antimony Sodium Gluconate